CMET-36. IMMUNOTHERAPY VERSUS STANDARD OF CARE IN MELANOMA BRAIN METASTASES WITH KNOWN BRAF STATUS

INTRO/OBJECTIVE: A mutation of the BRAF protein is seen in approximately 50% of melanoma patients. Immune checkpoint inhibitors (ICI) are standard therapy in melanoma patients independent of a patient’s BRAF status. The primary objective of this study is to investigate the impact of BRAF status in p...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Neuro Oncol
Huvudupphovsmän: Barnett, Addison, Sagar, Soumya, Lauko, Adam, (Auston) Wei, Wei, Chao, Samuel, Peereboom, David, Stevens, Glen, Angelov, Lilyana, Yu, Jennifer, Murphy, Erin, Mohammadi, Alireza, Suh, John, Barnett, Gene, Ahluwalia, Manmeet
Materialtyp: Artigo
Språk:Inglês
Publicerad: Oxford University Press 2019
Ämnen:
CNS Metastasis
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6847585/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.237
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk